WS20.4 Clinical outcomes of Real-World Kalydeco (CORK) study – a prospective 12 month analysis addressing the impact of CFTR modulation on the cystic fibrosis lung

Autor: Ronan, N.J., O'Callaghan, G.P., Mooney, D., Einarsson, G., Elborn, J.S., Ni Chroinin, M., Mullane, D., Murphy, D.M., O'Connor, O.J., Shortt, C., Tunney, M.M., Twomey, M., Maher, M.M., Eustace, J.A., Plant, B.J.
Zdroj: In Journal of Cystic Fibrosis June 2015 14 Supplement 1:S37-S37
Databáze: ScienceDirect